Skip to main content
All lobbying filings

EMD SERONO, INC.

Lobbying for EMD SERONO INC

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $900,000.00 expenses · posted Apr 21, 2025

Official filing document

 Bills named in this filing 7
  • HR 2214
    DRUG Act
  • S 864
    HELP Copays Act
  • S 882
    Patients Before Middlemen Act
  • S 891
    Bipartisan Health Care Act
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • S 832
    EPIC Act of 2025
  • HR 4346
    CHIPS and Science Act
 Lobbying activity 10
Science/Technology

P.L. 117-167: Supreme Court Security Funding Act of 2022 (H.R. 4346 -CHIPS and Science Act of 2022) - discussions related to ensuring program functionality

Trade (domestic/foreign)

Discussions related to tariffs

Health Issues

H.R. 2214: DRUG Act ; all provisions S. 864: HELP Copays Act; all provisions S. 882: Patients Before Middlemen Act; all provisions S. 891: Bipartisan Health Care Act; provisions related to Titles I, II, VIII, and IX Executive Order: Expanding Access to In Vitro Fertilization; all provisions of the order General discussions related to Pharmacy Benefit Manager policy issues General discussions related to Healthcare supply chain policy issues General discussions related to Drug cost and pricing policy issues General discussions related to caregiving support and awareness policy issues

Medicare/Medicaid

H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.; all provisions S. 832: EPIC Act of 2025; all provisions S. 891: Bipartisan Health Care Act; provisions related to Titles I, II, VIII, and IX General discussions related to Drug cost and pricing policy issues

Pharmacy

General discussions related to Drug cost and pricing policy issues General discussions related to Healthcare supply chain policy issues General discussions related to 340B Drug Pricing Program policy issues

Taxation/Internal Revenue Code

Discussions regarding 2025 Tax Reform efforts related to Research & Development (R & D) Tax Amortization, Base Erosion and Anti-Abuse Tax (BEAT), and Foreign Derived Intangible Income Tax (FDII)

Veterans

Discussions related to Veteran access to infertility care

Defense

Discussions related to Military access to infertility care

Copyright/Patent/Trademark

General discussions related to Biopharmaceutical innovation and patent policy issues

Labor Issues/Antitrust/Workplace

Discussions related to H1B Visas grace period

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem